Mark Winderlich - Apr 15, 2024 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Chief Development Officer
Signature
/s/ Reinhard Kandera, Attorney-in-Fact
Stock symbol
HOOK
Transactions as of
Apr 15, 2024
Transactions value $
$0
Form type
4
Date filed
4/17/2024, 04:15 PM
Previous filing
Apr 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOOK Stock Option (Right to Buy) Award $0 +250K $0.00 250K Apr 15, 2024 Common Stock 250K $0.76 Direct F1
transaction HOOK Stock Option (Right to Buy) Award $0 +50K $0.00 50K Apr 15, 2024 Common Stock 50K $0.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest on April 15, 2025, with the remainder vesting in 12 equal quarterly installments thereafter.